Results Snapshot
Figures in Rs cr
Consolidate Annual Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Net Sales
5,664.72
3,624.60
4,400.71
3,462.88
2,633.24
Other Operating Income
0.00
0.00
0.00
0.00
0.00
Total Operating income
5,664.72
3,624.60
4,400.71
3,462.88
2,633.24
Raw Material Cost
2,022.14
1,716.75
2,046.86
1,749.16
1,090.25
Purchase of Finished goods
23.07
15.59
25.67
16.20
18.67
(Increase) / Decrease In Stocks
127.89
-46.92
36.69
-273.49
-6.90
Employee Cost
1,256.89
403.26
338.57
311.36
277.66
Power Cost
229.99
124.84
95.05
74.59
78.50
Manufacturing Expenses
-0.01
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
Other Expenses
671.68
386.31
347.71
282.83
219.59
Total Expenditure (Excl Depreciation)
4,331.65
2,599.83
2,890.55
2,160.65
1,677.77
Operating Profit (PBDIT) excl Other Income
1,333.07
1,024.77
1,510.16
1,302.23
955.47
Other Income
170.24
240.46
223.94
134.78
139.17
Operating Profit (PBDIT)
1,503.31
1,265.23
1,734.10
1,437.01
1,094.64
Interest
26.20
7.45
5.24
3.41
7.18
Exceptional Items
0.00
-56.46
0.00
0.00
0.00
Gross Profit (PBDT)
1,477.11
1,201.32
1,728.86
1,433.60
1,087.46
Depreciation
344.57
146.74
110.30
98.78
94.59
Profit Before Tax
1,132.54
1,054.58
1,618.55
1,334.81
992.87
Tax
360.08
273.54
406.89
337.85
220.01
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
Profit After Tax
772.46
781.04
1,211.66
996.96
772.86
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
Net Profit
772.46
781.04
1,211.66
996.96
772.86
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
772.46
781.04
1,211.66
996.96
772.86
Equity Capital
16.47
16.47
16.43
16.36
15.50
Face Value
1.0
1.0
1.0
1.0
1.0
Reserves
8,707.37
7,942.25
7,141.19
5,886.88
3,630.74
Earnings per share (EPS)
46.9
47.42
73.75
60.94
49.86
Diluted Earnings per share
46.89
47.43
73.64
62.99
49.88
Operating Profit Margin (Excl OI)
23.53%
28.27%
34.32%
37.61%
36.28%
Gross Profit Margin
26.08%
33.14%
39.29%
41.4%
41.3%
PAT Margin
13.64%
21.55%
27.53%
28.79%
29.35%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2024 is 56.29% vs -17.64% in Mar 2023
Consolidate Net Profit
YoY Growth in year ended Mar 2024 is -1.10% vs -35.54% in Mar 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2024 is 30.08% vs -32.14% in Mar 2023
Interest
YoY Growth in year ended Mar 2024 is 251.68% vs 42.18% in Mar 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2024 has fallen from Mar 2023
Compare Annual Results Of Gland Pharma With
Figures in Rs cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
5,664.72
10,334.77
-4,670.05
-45.19%
Other Operating Income
0.00
0.00
0.00
Total Operating income
5,664.72
10,334.77
-4,670.05
-45.19%
Raw Material Cost
2,022.14
1,853.52
168.62
9.10%
Purchase of Finished goods
23.07
1,409.85
-1,386.78
-98.36%
(Increase) / Decrease In Stocks
127.89
-53.67
181.56
338.29%
Employee Cost
1,256.89
2,274.73
-1,017.84
-44.75%
Power Cost
229.99
0.00
229.99
Manufacturing Expenses
-0.01
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
671.68
2,315.28
-1,643.60
-70.99%
Total Expenditure (Excl Depreciation)
4,331.65
7,799.71
-3,468.06
-44.46%
Operating Profit (PBDIT) excl Other Income
1,333.07
2,535.06
-1,201.99
-47.41%
Other Income
170.24
280.86
-110.62
-39.39%
Operating Profit (PBDIT)
1,503.31
2,815.92
-1,312.61
-46.61%
Interest
26.20
33.53
-7.33
-21.86%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
1,477.11
2,782.39
-1,305.28
-46.91%
Depreciation
344.57
398.25
-53.68
-13.48%
Profit Before Tax
1,132.54
2,384.14
-1,251.60
-52.50%
Tax
360.08
457.58
-97.50
-21.31%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
772.46
1,926.56
-1,154.10
-59.90%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
772.46
1,926.56
-1,154.10
-59.90%
Share in Profit of Associates
0.00
15.21
-15.21
-100.00%
Minority Interest
0.00
-28.87
28.87
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
772.46
1,912.90
-1,140.44
-59.62%
Equity Capital
16.47
40.06
-23.59
-58.89%
Face Value
1.00
1.00
0.00
Reserves
8,707.37
9,323.03
-615.66
-6.60%
Earnings per share (EPS)
46.90
47.75
-0.85
-1.78%
Diluted Earnings per share
46.89
47.68
-0.79
-1.66%
Operating Profit Margin (Excl OI)
23.53%
24.53%
0.00
-1.00%
Gross Profit Margin
26.08%
26.92%
0.00
-0.84%
PAT Margin
13.64%
18.79%
0.00
-5.15%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 5,664.72 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 56.29% vs -17.64% in Mar 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 772.46 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is -1.10% vs -35.54% in Mar 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,333.07 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 30.08% vs -32.14% in Mar 2023
Annual - Interest
Interest 26.20 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 251.68% vs 42.18% in Mar 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 23.53%
in Mar 2024Figures in Rs %
YoY Growth in year ended Mar 2024 has fallen from Mar 2023